EP 2442785 A1 20120425 - AGENT FOR PREVENTING OR TREATING ABNORMALITY IN SKIN WATER PERMEATION FUNCTION
Title (en)
AGENT FOR PREVENTING OR TREATING ABNORMALITY IN SKIN WATER PERMEATION FUNCTION
Title (de)
MITTEL ZUR VERHINDERUNG BZW. BEHANDLUNG VON GESTÖRTER WASSERPERMEABILITÄTSFUNKTION DER HAUT
Title (fr)
AGENT DESTINE A PREVENIR OU A TRAITER UNE ANOMALIE DE LA FONCTION DE PERMEATION DE L'EAU DANS LA PEAU
Publication
Application
Priority
- JP 2010060796 W 20100618
- JP 2009146051 A 20090619
Abstract (en)
[origin: WO2010147238A1] An object of the present invention is to provide a skin water permeation function enhancer that can adjust TEWL according to the skin condition to thereby normalize skin water permeation function, thus enhancing skin water content regulation effect. Purine nucleic acid have an action of properly adjusting TEWL according to the skin condition, and are therefore used as an active ingredient of a skin water permeation function enhancer.
IPC 8 full level
A61K 8/60 (2006.01); A61K 31/7076 (2006.01); A61K 45/06 (2006.01); A61P 17/00 (2006.01)
CPC (source: EP KR)
A61K 8/60 (2013.01 - KR); A61K 8/606 (2013.01 - EP); A61K 31/7076 (2013.01 - EP KR); A61K 45/06 (2013.01 - KR); A61P 17/00 (2017.12 - EP); A61P 17/16 (2017.12 - EP); A61Q 19/08 (2013.01 - EP)
Citation (search report)
See references of WO 2010147238A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR
DOCDB simple family (publication)
WO 2010147238 A1 20101223; CN 102458351 A 20120516; CN 102458351 B 20140416; EP 2442785 A1 20120425; HK 1166705 A1 20121109; JP 2012530683 A 20121206; KR 20120032009 A 20120404
DOCDB simple family (application)
JP 2010060796 W 20100618; CN 201080027081 A 20100618; EP 10728911 A 20100618; HK 12107452 A 20120731; JP 2011553179 A 20100618; KR 20127001387 A 20100618